BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6229131)

  • 21. Plasma fibronectin concentration in germfree and conventional mice of various age.
    Cseh K; Anderlik P; Szeri I; Bános Z; Jakab L; Kalabay L
    Acta Microbiol Hung; 1989; 36(1):3-6. PubMed ID: 2603644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the lymphocytosis-stimulating factor of Bordetella pertussis].
    Veskova TK; Ravkina LI; Kulish EA
    Biull Eksp Biol Med; 1972 Jul; 73(7):82-5. PubMed ID: 5047734
    [No Abstract]   [Full Text] [Related]  

  • 23. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymological and morphological changes in rat intestinal mucosa following treatment with alkylating sugar alcohol derivatives.
    Prajda N; Kralovánszky J; Kerpel-Fronius S; Gál F; Szentirmay Z
    Anticancer Res; 1985; 5(4):451-6. PubMed ID: 4037742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
    Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
    APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study.
    Banus S; Bottema RW; Siezen CL; Vandebriel RJ; Reimerink J; Mommers M; Koppelman GH; Hoebee B; Thijs C; Postma DS; Kimman TG; Stelma FF
    Clin Vaccine Immunol; 2007 Oct; 14(10):1377-80. PubMed ID: 17699831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of lymphocytosis due to "Bordetella pertussis"].
    Morse SI
    Nouv Rev Fr Hematol; 1968; 8(5):541-8. PubMed ID: 4237381
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug sensitivity studies on clonal cell lines isolated from heteroploid tumor cell population. II. Sensitivity of clones growing in suspension cultures.
    Pályi I
    Neoplasma; 1980; 27(2):129-36. PubMed ID: 7393352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cell dynamics of the lymphatic system under the influence of antigen stimulation--difference between conventional and germ free mice].
    Watanabe S; Mikata A; Niki R; Kageyama K
    Saishin Igaku; 1971 Aug; 26(8):1425-36. PubMed ID: 5570220
    [No Abstract]   [Full Text] [Related]  

  • 31. Priming to heat shock proteins in infants vaccinated against pertussis.
    Del Giudice G; Gervaix A; Costantino P; Wyler CA; Tougne C; de Graeff-Meeder ER; van Embden J; van der Zee R; Nencioni L; Rappuoli R
    J Immunol; 1993 Mar; 150(5):2025-32. PubMed ID: 8094730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of Bordetella pertussis injection in newborn mice].
    Dobrek Z; Grèzes F; Salomon JC
    Nouv Rev Fr Hematol; 1971; 11(4):555-63. PubMed ID: 4332490
    [No Abstract]   [Full Text] [Related]  

  • 33. Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma.
    Ennis DP; Cassidy JP; Mahon BP
    Immunol Lett; 2005 Feb; 97(1):91-100. PubMed ID: 15626480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acellular Bordetella pertussis vaccine enhances mucosal interleukin-10 production, induces apoptosis of activated Th1 cells and attenuates colitis in Galphai2-deficient mice.
    Ohman L; Willén R; Hultgren OH; Hultgren Hörnquist E
    Clin Exp Immunol; 2005 Jul; 141(1):37-46. PubMed ID: 15958068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STUDIES ON THE LYMPHOCYTOSIS INDUCED IN MICE BY BORDETELLA PERTUSSIS.
    MORSE SI
    J Exp Med; 1965 Jan; 121(1):49-68. PubMed ID: 14253487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of germfree and SPF maintenance conditions on the lifespan and diseases of small laboratory animals.
    Deerberg F; Pittermann W
    J S Afr Vet Assoc; 1978 Sep; 49(3):179-82. PubMed ID: 154573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominance of resistance to the alkylating agent 1,2:5,6-dianhydrogalactitol in P388 mouse lymphoma hybrid cells.
    Pályi I; Bence J; Szikla K; Hullán L
    Cancer Chemother Pharmacol; 1989; 23(1):41-6. PubMed ID: 2909289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine lymphoma: augmented growth in mice with pertussis vaccine-induced lymphocytosis.
    Hirano M; Sinkovics JG; Shullenberger CC; Howe CD
    Science; 1967 Nov; 158(3804):1061-4. PubMed ID: 6058347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The lymphoid system of Toxoplasma infected mice.
    Csóka R; Császár S
    Acta Microbiol Hung; 1983; 30(1):43-6. PubMed ID: 6659852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of acellular pertussis vaccines-induced immunity against infection due to Bordetella pertussis variant isolates in a mouse model.
    Denoël P; Godfroid F; Guiso N; Hallander H; Poolman J
    Vaccine; 2005 Nov; 23(46-47):5333-41. PubMed ID: 16054273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.